Read an article Dr. Page was a contributor to about Biosimilars in oncology practices.
Dr. Page says, "Our practice is one of the pioneer practices participating in the ASCOs PracticeNET program, sharing benchmark data across a variety of oncology practices. We participated in the data, but more importantly, represented it through the authorship of the publication."
Read the Article
